Biochemical mechanism studies of venlafaxine by metabonomic method in rat model of depression

来源 :2012年广东省药师周大会 | 被引量 : 0次 | 上传用户:chenshuae5b
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Backbround:Venlafaxine is a new antidepressant that has a chemical structure and neuropharmacologic profile distinct from those of existing antidespressants.The studies about the mechanism of pharmacological action of venlafaxine mostly investigated the effects of venlafaxine on 5-HT,NE and DA levels,while only few studies examined the effects on the metabolites levels and ratio of these monoamines neurotransmitters.Aim:To study the biochemical mechanism of venlafaxine through determining the metabolism of monoamine neurotransmitters in brain tissues of rat model of depression after administration ofvenlafaxine using metabonomic method.Materials and methods:The rat model of depression was established by using the methods of separation and chronic unpredictable stress.The determination of 5-hydroxytryptamine (5-HT),norepinephrine (NE),dopamine (DA) and their metabolites,i.e.,5-hydroxyindole-3-acetic acid (5-HIAA),4-hrdroxy-3-methoxyphenylglycol (MHPG) sulfate,3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) in rat brain tissues by liquid chromatography-electrospray ionization tandem mass spectrometry (LC-ESI-MS/MS) following chronic administration of different venlafaxine doses (8,16,32mg·kg-1) and saline solution for 14 days.Linear discriminant analysis (LDA) and principal components analysis (PCA) were used in data analysis of metabonomic.Results:Compared with saline,venlafaxine could significantly increase brain 5-HT and NE levels at middle dose (16 mg·kg-1) or high dose (32 mg·kg-1),especially at middle dose.These increases were greater than those seen with the comparable dose of SSRI,fluoxetine,under the same experimental conditions.Conclusion:Venlafaxine lower brain neurotransmitter metabolite levels by decreasing brain neurotransmitters turnover.Venlafaxine could correct the disorder of neurotransmitters metabolism and coordinate the balance of 5-HT,NE and DA to reach the anti-depressed function.
其他文献
探讨医院制剂质量控制的现状和对策。本文对于目前医院制剂质量控制方面普遍存在的如何确定制剂有效期、原辅料和中药材的质量控制、直接接触药品包装材料的质量控制、制剂微生物限度检查方法验证和中药制剂有效成分定量等的问题及现状,提出和采取一些相应对策,供大家探讨。
当前,我国大力加强药品安全整治,总体形势明显好转,但药品安全问题并没有彻底解决,药品安全仍然呈现风险高发和矛盾凸显的特征,完善药品安全监管法规制度体系任重道远。本文分析了完善的药品安全监管法规制度体系应具备的基本要求,即基本法和具体法相结合的完备性,贯穿研发机构到用药人群的全程性,国内立法与国际立法接轨的开放性,各种法律法规之间相互协同的衔接性,以及兼顾城乡差异的区域协调性。进一步对药品安全监管法
The situation of career identity and job satisfaction among young hospital pharmacists in Guangdong,China was investigated.A mail-based questionnaire was sent to young hospital pharmacists in Guangdon
本文的目的是利用大鼠研究糖尿病皮肤对脂溶性的醋酸地塞米松(DA)和水溶性的地塞米松磷酸钠(DSP)经皮渗透和吸收作用的影响.在研究中采用了病理学方法观察糖尿病皮肤的病理改变,还同时引进了改良型Franz扩散池及微透析来评价上述两种药物的经皮渗透及吸收,并采用了高效液相或者液质联用的方法测定样品中DA和DSP的含量.结果表明,与正常大鼠相比,DA经糖尿病皮肤的渗透和吸收量无明显变化,而DSP经糖尿病
目的:比较三七总皂苷(PNS)与比索洛尔对急性心肌梗塞(AMI)后左室重构(LVRM)大鼠心功能作用.方法:除假手术组外采用结扎大鼠左冠状动脉前降支的方法建立AMI模型,术后24h后随机分为对照组和实验组,连续4w分别灌胃给予生理盐水2mg.kg-1、比索洛尔25mg.kg-1和PNS40、80、120 mg·kg-1,观察PNS和比索洛尔对病鼠室间隔舒张末期厚度(IVSd)、左室舒张末期内径(宽
目的:探讨哈蟆油(oR)对D-半乳糖所致雌性衰老大鼠肝脏组织p16、p21和cyclinD1蛋白表达的影响,进一步探讨OR延缓雌性大鼠机体衰老机制.方法:SPF级SD雌性青年大鼠40只随机分为模型组(D-gal组)、维生素E(VE组)、哈蟆油高剂量组(OR-H组)、中剂量组(OR-M组)、低剂量组(OR-L组),每组8只,D-半乳糖颈背部皮下注42d,建立亚急性衰老模型.另取雌性青年大鼠8只,同样
目的:研究芹菜素与柚皮素分别经大鼠空肠、回肠与结肠黏膜的体外区段透过特征.方法:采用体外垂直扩散池(Ussing Chamber)方法,分别评价50 μmol·L-1芹菜素及柚皮素经空肠、回肠和结肠黏膜经时(O~120min)吸收方向(M-S)与分泌方向(S-M)的累计透过率,并通过体系稳态时间(60min-120min)的累计透过率计算各区段吸收方向与分泌方向的表观渗透系数(Papp).芹菜素与
Purpose:The aim of this study was to test the ability of paclitaxel-loaded poly(butyl) cyanoacrylate (PBCA) nanoparticles to overcome multidrug resistance (MDR) in human ovarian resistant cells (A2780
Bone marrow mesenchyrnal stem cells (BMSC) can differentiate into diverse cell types,including adipogenic,osteogenic,chondrogenic and myogenic lineages.There are lots of BMSC accumulated in atheroscle
目的:探讨复方姜黄合剂对糖尿病大鼠视网膜新生血管的干预效果,并研究其剂量一疗效的关系.方法:STZ(链脲佐菌素)诱导糖尿病大鼠成功后,实验鼠随机分为合剂低剂量组、合剂中剂量组、合剂高剂量组、模型组、羟苯磺酸钙组,并设正常对照组.合剂组和羟苯磺酸钙组分别用复方姜黄合剂和羟苯磺酸钙,模型组和对照组用等容量蒸馏水灌胃.20周后,将实验大鼠处死.取眼球行视网膜消化铺片,观察血管形态,微血管数目,计算每高倍